Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
493 studies found for:    Open Studies | "Tissue Donors"
Show Display Options
Rank Status Study
21 Unknown  Evaluation of the Efficacy and Safety of Levothyroxine in Brain Death Organ Donors: a Randomized Controled Trial
Condition: Brain Dead Organ Donors
Interventions: Drug: Levothyroxine;   Drug: placebo
22 Recruiting The Effect of Anti-bacterial Honey Dressing on the Healing of Split Thickness Skin Graft Donor Site
Condition: Disorder of Skin Donor Site
Intervention: Device: medihoney dressing
23 Not yet recruiting Comparison of Postoperative Outcome of Hepatectomy for Living Donors According to Three Different Incision
Condition: Healthy Donors for Liver Transplantation
Interventions: Procedure: hepatectomy conventional incision;   Procedure: hepatectomy midline incision;   Procedure: hepatectomy transverse incision
24 Unknown  Efficacy Study Comparing Hand-Assisted Laparoscopic and Mini-Incision Muscle Splitting Incision Living Donor Nephrectomy
Condition: Living Donors
Intervention: Procedure: Living donornephrectomy
25 Unknown  A Prospective UK Multicentre Study of Kidney Donors
Condition: Living Kidney Donors
Intervention: Other: Nephrectomy
26 Recruiting Efficacy and Safety of Silk Fibroin With Bioactive Coating Layer Dressing
Conditions: Late Complication From Skin Graft;   Infection of Skin Donor Site;   Impaired Wound Healing;   Pain, Intractable
Interventions: Device: Silk fibroin with bioactive coating layer dressing;   Device: Bactigras wound dressing
27 Unknown  Pressure Controlled Versus Volume Controlled Mechanical Ventilation During Anesthesia for Living Donor Liver Transplantation Recipients
Condition: Living Donor Liver Transplantation Recipients
Intervention: Device: mechanical ventilation
28 Recruiting Treg Therapy in Subclinical Inflammation in Kidney Transplantation
Conditions: Kidney Transplant;   Adult Living Donor Kidney Transplant Recipients;   Renal Transplant;   Living Kidney Donor
Interventions: Biological: Polyclonal Regulatory T Cells;   Biological: Donor-Alloantigen-Reactive Regulatory T Cells;   Drug: Everolimus;   Drug: Tacrolimus;   Drug: Mycophenolate mofetil;   Drug: Mycophenolic acid;   Drug: Acetaminophen;   Drug: Diphenhydramine;   Procedure: Biopsy, Kidney;   Procedure: Blood Draw;   Procedure: Leukapheresis;   Procedure: IS regimen conversion
29 Recruiting Transcystic Versus Transanastomotic Tube Drainage in Right Lobe LDLT
Condition: Living Donor Liver Transplantation
Intervention: Device: biliary drainage tube
30 Recruiting Effects of Dexmedetomidine on Delirium After Living Donor Renal Transplantation in Adult Patients
Condition: Postoperative Delirium After Living Donor Renal Transplantation
Interventions: Drug: Dexmedetomidine;   Drug: Saline
31 Unknown  Haploidentical Transplantation With Early Adoptive Transfer of CD56+CD3- NK Cells
Conditions: Acute Myeloid Leukemias;   Advanced Hematological Malignancies;   Indication for Allogeneic Stem Cell Transplantation;   no HLA-identical Donor Available
Intervention: Biological: Haploidentical transplantation with donor NK cells
32 Recruiting Mesenchymal Stem Cell Infusion as Treatment for Steroid-Resistant Acute Graft Versus Host Disease (GVHD) or Poor Graft Function
Conditions: Graft-versus-host Disease;   Poor Graft Function;   Low Donor T-cell Chimerism
Intervention: Biological: Mesenchymal stem cells
33 Unknown  A Novel Approach to Endometrial Preparation in Recipients of Donor Eggs
Condition: Implantation, Embryo
Interventions: Drug: Leuprolide;   Drug: Ganirelix
34 Unknown  Protective Ventilatory Strategy in Potential Organ Donors
Condition: Mechanical Ventilation
Intervention: Procedure: change ventilation
35 Recruiting Donor Lymphocyte Infusion (DLI) of T-cells Genetically Modified With iCasp9 Suicide Gene
Conditions: Leukemia;   Myeloma;   Myeloproliferative Diseases
Interventions: Drug: Fludarabine;   Drug: Melphalan;   Drug: Alemtuzumab;   Procedure: Stem Cell infusion;   Drug: Tacrolimus;   Drug: Mini Methotrexate;   Drug: G-CSF;   Procedure: Donor Lymphocyte Infusion (DLI);   Drug: AP1903;   Drug: Methylprednisolone;   Behavioral: Questionnaire
36 Recruiting Quantitative Detection of Circulating Donor-Specific DNA in Organ Transplant Recipients (DTRT-Multi-Center Study)
Conditions: Cardiovascular Disease;   Acute Rejection of Cardiac Transplant;   Cardiac Transplant Rejection;   Heart Transplant Failure and Rejection
37 Available Expanded Access Protocol (EAP) Using the CliniMACS® Device for Pediatric Haplocompatible Donor Stem Cell Transplant
Conditions: Acute Lymphoblastic Leukemia;   Acute Myeloid Leukemia;   Chronic Myeloid Leukemia;   Myelodysplastic Syndrome;   Lymphomas;   Bone Marrow Failure;   Hemoglobinopathy;   Immune Deficiency;   Osteopetrosis;   Cytopenias;   Leukocyte Disorders;   Anemia Due to Intrinsic Red Cell Abnormality
Intervention: Biological: CD34+ enriched, T Cell Depleted donor stem cell product
38 Recruiting Donor Specific HLA Alloantibodies in Liver Transplantation
Condition: Complication of Transplanted Liver
Intervention: Other: HLA-alloantibodies exposure
39 Recruiting Cytapheresis of Volunteer Donors
Condition: Cytapheresis
40 Unknown  Extended Pancreas Donor Program - The EXPAND Study
Condition: Pancreas Allograft Recipients w/wo Kidney Transplantation

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years